Story thread · 3 reports / 3 sources
Lawsuit Against Bristol Myers Over Delayed Cancer Drug Is Revived
medscape.com · 4h · first report
How the coverage leans
Across 3 sources · syndicated copies counted once
A U.S. federal appeals court said a judge erred in dismissing a $6.7 billion lawsuit accusing Bristol Myers Squibb of cheating former Celgene shareholders by delaying... Reuters Health Information
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.